The efficacy and tolerability of amtolmetin guacyl (AMG), a new non-steroidal anti-inflammatory drug, were compared with piroxicam, in patients with osteoarthritis. In a randomized double-blind study patients with arthritis (n = 99) received either 600 mg AMG on an empty stomach or 20 mg of piroxicam on a full stomach, once daily for 30 days. All clinical parameters improved significantly with both drugs; there were no significant differences between the two treatments. Tolerability, assessed by the patients, was significantly better in the AMG group. In the piroxicam group nine of 50 patients withdrew because of side-effects (gastrointestinal) compared with two of 49 (nausea and headache) in the AMG group. There were three cases of perforation, ulcer and bleeding in the piroxicam group but no serious side-effects with AMG. Total numbers of side-effects were similar in the two groups, but epigastric and abdominal pain were more frequent and more intense with piroxicam. AMG was as effective as piroxicam in controlling the symptoms of osteoarthritis, but showed better gastrointestinal tolerability.

Download full-text PDF

Source
http://dx.doi.org/10.1177/147323000002800204DOI Listing

Publication Analysis

Top Keywords

amtolmetin guacyl
8
piroxicam patients
8
patients osteoarthritis
8
amg group
8
piroxicam group
8
piroxicam
7
amg
6
patients
5
guacyl versus
4
versus piroxicam
4

Similar Publications

Article Synopsis
  • - Childhood melanoma is a rare type of skin cancer in kids that can vary greatly in its biological characteristics.
  • - Diagnosing pediatric melanoma can be complicated because it shares similarities with various other tumors.
  • - A new fusion gene called MED15::ATF1 has been found in a specific case of aggressive pediatric melanoma that shows spitzoid features.
View Article and Find Full Text PDF

We report two novel cases of Xp11 translocation renal cell carcinomas with the gene fusion in adult females aged 40 and 74 years. Both cases were extensively cystic and contained only minimal clear cells lining cysts and within septal walls, raising the differential diagnosis of multilocular cystic renal neoplasm of low malignant potential. By immunohistochemistry, both neoplasms labeled for PAX8, TFE3, cathepsin K and Melan A but not for HMB45.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess how a 30-day treatment with amtolmetin guacil (AMG) affects adhesion molecules and vascular endothelial growth factor A in patients with active ankylosing spondylitis who didn't respond to prior NSAID therapy.
  • A total of 20 patients with active ankylosing spondylitis and 10 healthy controls were evaluated for adhesion molecules and other inflammatory markers before and after the AMG treatment.
  • Results showed significant reductions in certain adhesion molecules (sICAM-1 and sVCAM-1) in patients with ankylosing spondylitis after the AMG treatment, suggesting potential benefits for those unresponsive to previous NSAIDs.
View Article and Find Full Text PDF

Celecoxib for rheumatoid arthritis.

Cochrane Database Syst Rev

June 2017

Medical faculty, University of Tuzla, Univerzitetska 1, Tuzla, Canton Tuzla, Bosnia and Herzegovina, 75000.

Background: Rheumatoid arthritis is a systemic auto-immune disorder that causes widespread and persistent inflammation of the synovial lining of joints and tendon sheaths. Presently, there is no cure for rheumatoid arthritis and treatment focuses on managing symptoms such as pain, stiffness and mobility, with the aim of achieving stable remission and improving mobility. Celecoxib is a selective non-steroidal anti-inflammatory drug (NSAID) used for treatment of people with rheumatoid arthritis.

View Article and Find Full Text PDF

Amtolmetin: A Reappraisal of NSAID with Gastroprotection.

Arthritis

April 2016

Global Medical Affairs, Dr. Reddy's Laboratories Ltd., Hyderabad 500034, India.

Aim. To assess the gastrosparing effect of amtolmetin guacyl (AMG) against other nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with osteo-/rheumatoid arthritis. Methods.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!